PHASE II OPEN-LABEL STUDY OF SINGLE-AGENT HYDROXYUREA FOR TREATMENT OF ADVANCED CUTANEOUS MAST CELL TUMORS IN DOGS

机译：单药羟基脲的第II期开放标签研究，用于治疗犬晚皮腰肿瘤瘤

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

Hydroxyurea (HU), a ribonucleotide reductase inhibitor, used mainly to treat myeloproliferative diseases, also exhibits antitumor activity against several human solid tumors. This prospective study evaluated the efficacy and safety of HU in dogs withmeasurable mast cell tumors that were resistant to previous chemotherapy.

机译：羟基脲（Hu），一种主要用于治疗髓鳞状疾病的核糖核苷酸还原酶抑制剂，也表现出对几种人类实体瘤的抗肿瘤活性。该前瞻性研究评估了HU在犬毒性肥大细胞肿瘤中的疗效和安全性对先前化疗的疗效。

著录项

来源
《Annual Conference of the Veterinary Cancer Society》|2009年||共1页
会议地点
作者
Ken Rassnick; Renee Al-Sarraf; Dennis Bailey; Cheryl Balkman; Joanne Intile; Sandra Barnard; Erin Malone; Andi Flory; Mike Kiselow; John Chretin; Brenda Phillips; Courtney Zwhalen; Nicole Northrup;
展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种
中图分类 S857.4-532;
关键词
入库时间 2022-08-20 19:50:06

相似文献

外文文献
中文文献
专利

1. 羟基喜树碱冻干粉针(拓僖)单药治疗晚期恶性肿瘤临床研究的初步报告 [J] . 黄慧强, 姜文奇, 胡晓桦, 癌症（英文版） . 2003,第012期
2. Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs. [J] . Rassnick K. M., Al-Sarraf R., Bailey D. B., Veterinary and Comparative Oncology . 2010,第2期

机译：单剂羟基脲治疗犬肥大细胞肿瘤的II期开放标签研究。
3. Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer. [J] . Cufer T, Vrdoljak E, Gaafar R, Anti-cancer drugs . 2006,第4期

机译：II期单项药物吉非替尼（IRESSA）或多西他赛为二线治疗的开放式随机研究（SIGN），用于晚期（IIIb或IV期）非小细胞肺癌患者。
4. A Phase II Clinical Trial of Vinorelbine in Dogs with Cutaneous Mast Cell Tumors. [J] . Grant IA, Rodriguez CO, Kent MS, Journal of Veterinary Internal Medicine . 2008,第2期

机译：长春瑞滨在具有皮肤肥大细胞瘤的犬中的II期临床试验。
5. PHASE II OPEN-LABEL STUDY OF SINGLE-AGENT HYDROXYUREA FOR TREATMENT OF ADVANCED CUTANEOUS MAST CELL TUMORS IN DOGS [C] . Ken Rassnick, Renee Al-Sarraf, Dennis Bailey, Annual Conference of the Veterinary Cancer Society . 2009

机译：单药羟基脲的第II期开放标签研究，用于治疗犬晚皮腰肿瘤瘤
6. Hereditary deafness and mast cell tumors in dogs: Sequence analysis of candidate genes from the melanocyte development pathway. [D] . Zemke, Daniel. 2003

机译：狗的遗传性耳聋和肥大细胞肿瘤：黑色素细胞发育途径中候选基因的序列分析。
7. A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer [O] . Athanasios G Pallis, Sophia Agelaki, Athina Agelidou, 2010

机译：多西他赛/卡铂联合与多西他赛单药作为二线治疗晚期/转移性非小细胞肺癌患者的随机III期研究
8. Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer [O] . OBrien Mary E.R., Socinski Mark A., Popovich Alexander Y., 2008

机译：比较单药紫杉醇Poliglumex（CT-2103，PPX）与单药吉西他滨或长春瑞滨治疗PS 2初治性晚期非小细胞肺癌患者的随机III期试验
9. ACTG 320: A Randomized Double-Blind, Phase III Study of Indinavir Sulfate (IDV) with Open-Label ZDV or Stavudine (d4T) and Lamivudine (3TC) in Subjects with HIV Infection with CD4 Cell Counts < = 200 Cells/mm3 and > = 3 Months of Prior Zidovudine Experien [R] . 1997

机译：aCTG 320：一项随机双盲，III期研究的印地那韦硫酸盐（IDV）与开放标签ZDV或司他夫定（d4T）和拉米夫定（3TC）的HIV感染受试者CD4细胞计数<= 200个细胞/ mm3和> = 3个月的Zidovudine Experien

PHASE II OPEN-LABEL STUDY OF SINGLE-AGENT HYDROXYUREA FOR TREATMENT OF ADVANCED CUTANEOUS MAST CELL TUMORS IN DOGS

摘要

著录项

相似文献

相关主题

期刊订阅